Vasileios Papastamopoulos - Infectious Diseases

Author Information

Vasileios Papastamopoulos is affiliated with the 5th Department of Medicine and Infectious Diseases at Evaggelismos General Hospital in Athens, Greece. His research primarily focuses on infectious diseases, with a particular emphasis on HIV-1 transmission dynamics and treatment strategies.

Research Contributions

Vasileios Papastamopoulos has made significant contributions to the understanding of HIV-1 transmission and treatment in Greece. His research includes studying the origin and transmission rates of major HIV-1 clusters, examining the HIV continuum of care, and assessing the impact of early treatment initiation on transmission rates. Additionally, his work has explored the prevalence of drug resistance among treatment-naïve HIV-1 patients and compared cardiovascular risk factors in HIV-infected individuals with the general population.

Aliases

Vasileios Papastamopoulos is also known by other names, including V Papastamopoulos and V. Papastamopoulos. These variations are used interchangeably in his publications.

Publication and Citation Metrics

Metric	Value
Total Citations	293
H-index	8
Number of Papers	20

Publications:

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

DOI: 10.3390/v14010101

Year: 2022

HIV continuum of care: bridging cross-sectional and longitudinal analyses

DOI: 10.1097/QAD.0000000000003131

Year: 2021

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

DOI: 10.1136/sextrans-2020-054509

Year: 2020

Evolocumab in HIV-Infected Patients With Dyslipidemia

DOI: 10.1016/j.jacc.2020.03.025

Year: 2020

Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece

DOI: 10.1371/journal.pone.0230730

Year: 2020

A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters

DOI: 10.3390/v12101183

Year: 2020

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1

DOI: 10.1097/QAD.0000000000002126

Year: 2019

Associations between baseline biomarkers and lung function in HIV-positive individuals

DOI: 10.1097/QAD.0000000000002101

Year: 2019

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health

DOI: 10.3390/genes8110322

Year: 2017

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

DOI: 10.1016/j.meegid.2017.07.003

Year: 2017

What are Zoonoses?

What Are the Side Effects of Antimalarial Drugs?

What Role Do Surveillance Systems Play in Global Health?

What is the Importance of Education in Infectious Diseases?

What is Dengue?

How should Dexamethasone be administered?

How Do Infectious Agents Influence Epigenetics?

Why Are Antiemetics Important in Infectious Diseases?

Are there specific populations at higher risk for drug interactions?

What is an Apicoplast?

Partnered Content Networks

Relevant Topics